4//SEC Filing
PAREKH RAJESH B 4
Accession 0001104659-22-072185
CIK 0001035354other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:27 AM ET
Size
6.0 KB
Accession
0001104659-22-072185
Insider Transaction Report
Form 4
PAREKH RAJESH R
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-06-15+20,000→ 20,000 totalExercise: $0.26Exp: 2032-06-15→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter.
- [F2]The Reporting Person will assign the economic interests of this grant to Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001429930
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:27 AM ET
- Size
- 6.0 KB